Scotiabank Has Lowered Expectations for WELL Health Technologies (TSE:WELL) Stock Price

WELL Health Technologies (TSE:WELL) had its price objective dropped by analysts at Scotiabank from C$7.00 to C$6.50 in a report released on Wednesday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. Scotiabank’s price objective would suggest a potential upside of 58.54% from the company’s current price.

Separately, CIBC raised shares of WELL Health Technologies from a “neutral” rating to an “outperform” rating in a report on Wednesday, December 3rd. Six investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, WELL Health Technologies presently has an average rating of “Buy” and an average price target of C$7.35.

WELL Health Technologies Trading Up 3.8%

WELL stock traded up C$0.15 on Wednesday, hitting C$4.10. 1,843,484 shares of the company were exchanged, compared to its average volume of 1,303,515. The company has a debt-to-equity ratio of 46.79, a current ratio of 1.14 and a quick ratio of 1.02. The stock has a market capitalization of C$1.04 billion, a price-to-earnings ratio of -45.56, a price-to-earnings-growth ratio of -1.93 and a beta of 0.49. WELL Health Technologies has a twelve month low of C$3.58 and a twelve month high of C$6.36. The business’s fifty day moving average is C$4.02 and its two-hundred day moving average is C$4.53.

WELL Health Technologies (TSE:WELL) last announced its quarterly earnings results on Thursday, November 6th. The company reported C$0.16 earnings per share for the quarter. The firm had revenue of C$364.60 million during the quarter. WELL Health Technologies had a net margin of 7.67% and a return on equity of 8.74%. As a group, research analysts forecast that WELL Health Technologies will post 0.3000698 earnings per share for the current year.

WELL Health Technologies Company Profile

WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.